当前位置:首页 - 行情中心 - 常山药业(300255) - 财务分析 - 现金流量表

常山药业

(300255)

  

流通市值:432.87亿  总市值:433.70亿
流通股本:9.17亿   总股本:9.19亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金548,877,594.72266,030,861.291,046,319,008.4787,272,377.4
  收到的税费返还8,165,041.857,375,821.0935,837,247.7233,255,087.35
  收到其他与经营活动有关的现金21,452,714.7912,459,631.0527,275,067.8142,433,202.33
  经营活动现金流入小计578,495,351.36285,866,313.431,109,431,323.93862,960,667.08
  购买商品、接受劳务支付的现金239,851,756.74115,797,697.8672,853,071.66377,798,177.31
  支付给职工以及为职工支付的现金81,569,342.4535,781,479.42162,128,158.79135,967,611.78
  支付的各项税费25,288,771.256,926,658.6958,666,812.7244,454,438.35
  支付其他与经营活动有关的现金58,577,680.7424,368,174.5159,565,110.69154,393,808.47
  经营活动现金流出小计405,287,551.18182,874,010.411,053,213,153.86712,614,035.91
  经营活动产生的现金流量净额173,207,800.18102,992,303.0256,218,170.07150,346,631.17
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额--58,000-
  收到的其他与投资活动有关的现金106,060,00030,00011,265,615.92625,000
  投资活动现金流入小计106,060,00030,00011,323,615.92625,000
  购建固定资产、无形资产和其他长期资产支付的现金47,570,898.2228,937,497.16239,590,962.09117,908,224.76
  支付其他与投资活动有关的现金106,283,000228,0005,495,162998,000
  投资活动现金流出小计153,853,898.2229,165,497.16245,086,124.09118,906,224.76
  投资活动产生的现金流量净额-47,793,898.22-29,135,497.16-233,762,508.17-118,281,224.76
三、筹资活动产生的现金流量:
  取得借款收到的现金965,324,418.63219,323,168.631,894,898,9101,705,760,860
  收到其他与筹资活动有关的现金64,000,0002,283,817.15106,298,981.93-
  筹资活动现金流入小计1,029,324,418.63221,606,985.782,001,197,891.931,705,760,860
  偿还债务支付的现金1,062,423,078.52217,817,383.891,685,212,782.941,559,812,581.77
  分配股利、利润或偿付利息支付的现金59,262,110.8329,164,860.34119,928,863.5981,485,379.18
  支付其他与筹资活动有关的现金55,182,0006,465,445.8314,322,84513,440,905.47
  筹资活动现金流出小计1,176,867,189.35253,447,690.061,819,464,491.531,654,738,866.42
  筹资活动产生的现金流量净额-147,542,770.72-31,840,704.28181,733,400.451,021,993.58
四、汇率变动对现金及现金等价物的影响2,654,762.671,176,593.01839,298.48244,412.69
五、现金及现金等价物净增加额-19,474,106.0943,192,694.595,028,360.7883,331,812.68
  加:期初现金及现金等价物余额235,886,780.62235,970,467.3230,858,419.84230,858,419.84
  期末现金及现金等价物余额216,412,674.53279,163,161.89235,886,780.62314,190,232.52
补充资料:
  净利润-36,220,597.35--264,031,841.21-
  资产减值准备-18,787,985.13-89,387,147.3-
  固定资产和投资性房地产折旧28,894,830.57-61,014,651.52-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,894,830.57-61,014,651.52-
  无形资产摊销4,735,575.43-11,336,402.03-
  长期待摊费用摊销1,620,735.06-1,050,676.66-
  处置固定资产、无形资产和其他长期资产的损失-17,641.19-63,301.42-
  固定资产报废损失29,659.01-711,844.68-
  财务费用48,924,439.19-102,830,310.85-
  投资损失---33,263,558.02-
  递延所得税3,078,696.67--970,586.45-
  其中:递延所得税资产减少3,099,897.34--928,185.07-
    递延所得税负债增加-21,200.67--42,401.38-
  存货的减少126,327,489.38-190,001,583.12-
  经营性应收项目的减少-124,267,569.38--21,010,245.1-
  经营性应付项目的增加137,691,798.4--82,245,575.24-
  现金的期末余额216,412,674.53-235,886,780.62-
  减:现金的期初余额235,886,780.62-230,858,419.84-
  现金及现金等价物的净增加额-19,474,106.09-5,028,360.78-
公告日期2025-08-232025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑